GTPL Hathway Ltd: Share Price Analysis, Intrinsic Value & Fundamentals (2025)

Share Price and Basic Stock Data

Last Updated: March 8, 2025, 1:55 pm

Competitors of GTPL Hathway Ltd

All Competitor Stocks of GTPL Hathway Ltd

Quarterly Result

Last Updated: February 28, 2025, 7:40 pm

Below is a detailed analysis of the quarterly data for GTPL Hathway Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

• For Sales, as of Dec 2024, the value is ₹887.27 Cr.. The value appears strong and on an upward trend. It has increased from 855.56 Cr. (Sep 2024) to ₹887.27 Cr., marking an increase of ₹31.71 Cr..
• For Expenses, as of Dec 2024, the value is ₹781.89 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 748.19 Cr. (Sep 2024) to ₹781.89 Cr., marking an increase of ₹33.70 Cr..
• For Operating Profit, as of Dec 2024, the value is ₹105.38 Cr.. The value appears to be declining and may need further review. It has decreased from 107.37 Cr. (Sep 2024) to ₹105.38 Cr., marking a decrease of 1.99 Cr..
• For OPM %, as of Dec 2024, the value is 11.88%. The value appears to be declining and may need further review. It has decreased from 12.55% (Sep 2024) to 11.88%, marking a decrease of 0.67%.
• For Other Income, as of Dec 2024, the value is ₹9.31 Cr.. The value appears strong and on an upward trend. It has increased from 7.12 Cr. (Sep 2024) to ₹9.31 Cr., marking an increase of ₹2.19 Cr..
• For Interest, as of Dec 2024, the value is ₹8.65 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 6.03 Cr. (Sep 2024) to ₹8.65 Cr., marking an increase of ₹2.62 Cr..
• For Depreciation, as of Dec 2024, the value is ₹92.75 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 90.48 Cr. (Sep 2024) to ₹92.75 Cr., marking an increase of ₹2.27 Cr..
• For Profit before tax, as of Dec 2024, the value is ₹13.29 Cr.. The value appears to be declining and may need further review. It has decreased from 17.98 Cr. (Sep 2024) to ₹13.29 Cr., marking a decrease of 4.69 Cr..
• For Tax %, as of Dec 2024, the value is 27.46%. The value appears to be increasing, which may not be favorable. It has increased from 23.64% (Sep 2024) to 27.46%, marking an increase of 3.82%.
• For Net Profit, as of Dec 2024, the value is ₹9.63 Cr.. The value appears to be declining and may need further review. It has decreased from 13.74 Cr. (Sep 2024) to ₹9.63 Cr., marking a decrease of 4.11 Cr..
• For EPS in Rs, as of Dec 2024, the value is 0.90. The value appears to be declining and may need further review. It has decreased from ₹1.14 (Sep 2024) to 0.90, marking a decrease of ₹0.24.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: March 6, 2025, 4:08 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: October 15, 2024, 3:41 pm

Below is a detailed analysis of the balance sheet data for GTPL Hathway Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2024, the value is ₹112.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹112.00 Cr..
• For Reserves, as of Sep 2024, the value is ₹1,030.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹1,047.00 Cr. (Mar 2024) to ₹1,030.00 Cr., marking a decrease of 17.00 Cr..
• For Borrowings, as of Sep 2024, the value is ₹325.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from ₹242.00 Cr. (Mar 2024) to ₹325.00 Cr., marking an increase of 83.00 Cr..
• For Other Liabilities, as of Sep 2024, the value is ₹1,986.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹1,617.00 Cr. (Mar 2024) to ₹1,986.00 Cr., marking an increase of 369.00 Cr..
• For Total Liabilities, as of Sep 2024, the value is ₹3,454.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹3,019.00 Cr. (Mar 2024) to ₹3,454.00 Cr., marking an increase of 435.00 Cr..
• For Fixed Assets, as of Sep 2024, the value is ₹2,028.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹2,029.00 Cr. (Mar 2024) to ₹2,028.00 Cr., marking a decrease of 1.00 Cr..
• For CWIP, as of Sep 2024, the value is ₹96.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹88.00 Cr. (Mar 2024) to ₹96.00 Cr., marking an increase of 8.00 Cr..
• For Investments, as of Sep 2024, the value is ₹12.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹11.00 Cr. (Mar 2024) to ₹12.00 Cr., marking an increase of 1.00 Cr..
• For Other Assets, as of Sep 2024, the value is ₹1,319.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹891.00 Cr. (Mar 2024) to ₹1,319.00 Cr., marking an increase of 428.00 Cr..
• For Total Assets, as of Sep 2024, the value is ₹3,454.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹3,019.00 Cr. (Mar 2024) to ₹3,454.00 Cr., marking an increase of 435.00 Cr..

Notably, the Reserves (₹1,030.00 Cr.) exceed the Borrowings (325.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for GTPL Hathway Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 24, the value is 9.51. This value is within the healthy range. It has decreased from 10.13 (Mar 23) to 9.51, marking a decrease of 0.62.
• For Diluted EPS (Rs.), as of Mar 24, the value is 9.51. This value is within the healthy range. It has decreased from 10.13 (Mar 23) to 9.51, marking a decrease of 0.62.
• For Cash EPS (Rs.), as of Mar 24, the value is 39.94. This value is within the healthy range. It has increased from 39.39 (Mar 23) to 39.94, marking an increase of 0.55.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 103.13. It has decreased from 107.57 (Mar 23) to 103.13, marking a decrease of 4.44.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 103.13. It has decreased from 107.57 (Mar 23) to 103.13, marking a decrease of 4.44.
• For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 285.65. It has increased from 236.87 (Mar 23) to 285.65, marking an increase of 48.78.
• For PBDIT / Share (Rs.), as of Mar 24, the value is 45.45. This value is within the healthy range. It has decreased from 45.91 (Mar 23) to 45.45, marking a decrease of 0.46.
• For PBIT / Share (Rs.), as of Mar 24, the value is 15.47. This value is within the healthy range. It has decreased from 17.55 (Mar 23) to 15.47, marking a decrease of 2.08.
• For PBT / Share (Rs.), as of Mar 24, the value is 13.43. This value is within the healthy range. It has decreased from 14.99 (Mar 23) to 13.43, marking a decrease of 1.56.
• For Net Profit / Share (Rs.), as of Mar 24, the value is 9.96. This value is within the healthy range. It has decreased from 11.03 (Mar 23) to 9.96, marking a decrease of 1.07.
• For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 9.51. This value is within the healthy range. It has decreased from 10.13 (Mar 23) to 9.51, marking a decrease of 0.62.
• For PBDIT Margin (%), as of Mar 24, the value is 15.91. This value is within the healthy range. It has decreased from 19.38 (Mar 23) to 15.91, marking a decrease of 3.47.
• For PBIT Margin (%), as of Mar 24, the value is 5.41. This value is below the healthy minimum of 10. It has decreased from 7.41 (Mar 23) to 5.41, marking a decrease of 2.00.
• For PBT Margin (%), as of Mar 24, the value is 4.70. This value is below the healthy minimum of 10. It has decreased from 6.32 (Mar 23) to 4.70, marking a decrease of 1.62.
• For Net Profit Margin (%), as of Mar 24, the value is 3.48. This value is below the healthy minimum of 5. It has decreased from 4.65 (Mar 23) to 3.48, marking a decrease of 1.17.
• For NP After MI And SOA Margin (%), as of Mar 24, the value is 3.33. This value is below the healthy minimum of 8. It has decreased from 4.27 (Mar 23) to 3.33, marking a decrease of 0.94.
• For Return on Networth / Equity (%), as of Mar 24, the value is 9.22. This value is below the healthy minimum of 15. It has decreased from 10.32 (Mar 23) to 9.22, marking a decrease of 1.10.
• For Return on Capital Employeed (%), as of Mar 24, the value is 11.66. This value is within the healthy range. It has decreased from 14.73 (Mar 23) to 11.66, marking a decrease of 3.07.
• For Return On Assets (%), as of Mar 24, the value is 3.50. This value is below the healthy minimum of 5. It has decreased from 4.20 (Mar 23) to 3.50, marking a decrease of 0.70.
• For Long Term Debt / Equity (X), as of Mar 24, the value is 0.05. This value is below the healthy minimum of 0.2. It has increased from 0.02 (Mar 23) to 0.05, marking an increase of 0.03.
• For Total Debt / Equity (X), as of Mar 24, the value is 0.19. This value is within the healthy range. It has increased from 0.12 (Mar 23) to 0.19, marking an increase of 0.07.
• For Asset Turnover Ratio (%), as of Mar 24, the value is 1.11. It has increased from 1.05 (Mar 23) to 1.11, marking an increase of 0.06.
• For Current Ratio (X), as of Mar 24, the value is 0.46. This value is below the healthy minimum of 1.5. It has decreased from 0.48 (Mar 23) to 0.46, marking a decrease of 0.02.
• For Quick Ratio (X), as of Mar 24, the value is 0.44. This value is below the healthy minimum of 1. It has decreased from 0.45 (Mar 23) to 0.44, marking a decrease of 0.01.
• For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 42.04. This value is within the healthy range. It has increased from 39.47 (Mar 23) to 42.04, marking an increase of 2.57.
• For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 10.12. This value is below the healthy minimum of 20. It has decreased from 10.39 (Mar 23) to 10.12, marking a decrease of 0.27.
• For Earning Retention Ratio (%), as of Mar 24, the value is 57.96. This value is within the healthy range. It has decreased from 60.53 (Mar 23) to 57.96, marking a decrease of 2.57.
• For Cash Earning Retention Ratio (%), as of Mar 24, the value is 89.88. This value exceeds the healthy maximum of 70. It has increased from 89.61 (Mar 23) to 89.88, marking an increase of 0.27.
• For Interest Coverage Ratio (X), as of Mar 24, the value is 22.32. This value is within the healthy range. It has decreased from 52.03 (Mar 23) to 22.32, marking a decrease of 29.71.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 5.89. This value is within the healthy range. It has decreased from 15.41 (Mar 23) to 5.89, marking a decrease of 9.52.
• For Enterprise Value (Cr.), as of Mar 24, the value is 2,083.42. It has increased from 1,130.62 (Mar 23) to 2,083.42, marking an increase of 952.80.
• For EV / Net Operating Revenue (X), as of Mar 24, the value is 0.64. This value is below the healthy minimum of 1. It has increased from 0.42 (Mar 23) to 0.64, marking an increase of 0.22.
• For EV / EBITDA (X), as of Mar 24, the value is 4.08. This value is below the healthy minimum of 5. It has increased from 2.19 (Mar 23) to 4.08, marking an increase of 1.89.
• For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 0.58. This value is below the healthy minimum of 1. It has increased from 0.41 (Mar 23) to 0.58, marking an increase of 0.17.
• For Retention Ratios (%), as of Mar 24, the value is 57.95. This value is within the healthy range. It has decreased from 60.52 (Mar 23) to 57.95, marking a decrease of 2.57.
• For Price / BV (X), as of Mar 24, the value is 1.62. This value is within the healthy range. It has increased from 0.99 (Mar 23) to 1.62, marking an increase of 0.63.
• For Price / Net Operating Revenue (X), as of Mar 24, the value is 0.58. This value is below the healthy minimum of 1. It has increased from 0.41 (Mar 23) to 0.58, marking an increase of 0.17.
• For EarningsYield, as of Mar 24, the value is 0.05. This value is below the healthy minimum of 5. It has decreased from 0.10 (Mar 23) to 0.05, marking a decrease of 0.05.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness